EKG vs. CNCR
EKG (First Trust Nasdaq Lux Digital Health Solutions ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds - EKG tracks the NASDAQ Lux Health Tech Index while CNCR tracks the Loncar Cancer Immunotherapy Index. Both are passively managed. EKG charges 0.65%/yr vs 0.79%/yr for CNCR.
Performance
EKG vs. CNCR - Performance Comparison
Loading charts...
Returns By Period
EKG
- 1D
- -0.20%
- 1M
- 2.98%
- YTD
- -10.11%
- 6M
- -12.99%
- 1Y
- -0.93%
- 3Y*
- -0.66%
- 5Y*
- —
- 10Y*
- —
CNCR
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
EKG vs. CNCR - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
EKG First Trust Nasdaq Lux Digital Health Solutions ETF | -4.48% |
CNCR Loncar Cancer Immunotherapy ETF | 0.00% |
EKG vs. CNCR - Sectors Allocation Comparison
Sectors
EKG
CNCR
Healthcare
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
EKG
CNCR
Technology
EKG
CNCR
-
Basic Materials
EKG
-
CNCR
-
Communication Services
EKG
-
CNCR
-
Consumer Cyclical
EKG
-
CNCR
-
Consumer Defensive
EKG
-
CNCR
-
Energy
EKG
-
CNCR
-
Financial Services
EKG
-
CNCR
Industrials
EKG
-
CNCR
-
Real Estate
EKG
-
CNCR
-
Utilities
EKG
-
CNCR
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EKG vs. CNCR — Risk / Return Rank
EKG
CNCR
EKG vs. CNCR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EKG | CNCR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.01 | — | — |
| Calmar ratioReturn relative to maximum drawdown | -0.04 | — | — |
| Martin ratioReturn relative to average drawdown | -0.10 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EKG | CNCR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.04 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.13 | — | — |
Drawdowns
EKG vs. CNCR - Drawdown Comparison
The maximum EKG drawdown since its inception was -43.82%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for EKG and CNCR.
Loading charts...
Drawdown Indicators
| EKG | CNCR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -43.82% | 0.00% | -43.82% |
Max Drawdown (1Y)Largest decline over 1 year | -22.09% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -34.49% | — | — |
Current DrawdownCurrent decline from peak | -20.78% | 0.00% | -20.78% |
Average DrawdownAverage peak-to-trough decline | -22.66% | 0.00% | -22.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.73% | — | — |
Volatility
EKG vs. CNCR - Volatility Comparison
Loading charts...
Volatility by Period
| EKG | CNCR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.09% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 16.42% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 21.57% | 0.00% | +21.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.07% | 0.00% | +27.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.07% | 0.00% | +27.07% |
EKG vs. CNCR - Expense Ratio Comparison
EKG has a 0.65% expense ratio, which is lower than CNCR's 0.79% expense ratio.
Dividends
EKG vs. CNCR - Dividend Comparison
Neither EKG nor CNCR has paid dividends to shareholders.
Frequently Asked Questions
On fees, EKG is cheaper at 0.65% per year. The better choice depends on whether you care most about return, fees, risk, or income.
EKG is cheaper with a 0.65% expense ratio, compared with 0.79% for CNCR.
EKG and CNCR have nearly identical dividend yields, around 0.00%.
EKG tracks NASDAQ Lux Health Tech Index, while CNCR tracks Loncar Cancer Immunotherapy Index. They also come from different issuers: First Trust and Exchange Traded Concepts. Their fees differ too: 0.65% for EKG and 0.79% for CNCR.
Find the right allocation for EKG and CNCR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer